Insights from 2023 ESMO Asia Annual Meeting

 

Lung
10:08

Insights from 2023 ESMO Asia Annual Meeting

Oncogene-Driven NSCLC: RET, NTRK, and ROS1

FEATURING Junko Tanizaki
  • 405 views
  • February 7, 2024
09:17

Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Summary: "Befotertinib, Osimertinib, Telisotuzumab Vedotin, and MCLA-129 in Locally Advanced/Metastatic NSCLC"

FEATURING Junko Tanizaki
  • 88 views
  • February 7, 2024
06:58

Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "Efficacy & Safety of MCLA-129, an Anti-EGFR/c-MET Bispecific Antibody, Combined With Osimertinib, as 1L Therapy or After Progression on Osimertinib in NSCLC"

FEATURING Mariana Brandão
  • 82 views
  • January 17, 2024
  • 3
06:57

Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "TROPION-Lung01 Study - Dato-DXd vs. Docetaxel in Previously Treated Advanced/Metastatic NSCLC"

FEATURING Myung-Ju Ahn
  • 111 views
  • January 3, 2024
  • 1
06:45

Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "DeLLphi-301 Study - Tarlatamab for Patients With Previously Treated SCLC"

FEATURING Myung-Ju Ahn
  • 158 views
  • January 3, 2024
13:20

Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "EGFR TKIs in NSCLC - Which One, How Long, When, and Who"

FEATURING Masahiro Tsuboi
  • 53 views
  • January 3, 2024
  • 1